A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 28 (11), 2820-2826, 2017-11
Elsevier BV